As part of its rulemaking process, the U.S. Food and Drug Administration (FDA) is required to conduct an economic impact analysis that assesses the costs and benefits of proposed regulations and to select the option that maximizes the net economic benefit. There are numerous challenges inherent in conducting this type of analysis, from fully.assessing the various costs and benefits of proposed rules to quantifying these costs and benefits, often with incomplete data and evidence. The comments provided to FDA on the economic impact analysis contained in its proposed rule on required warnings for cigarette packages and advertisements highlighted these challenges. The overarching aim of this project is to produce new evidence that will inform and refine the FDA's economic impact assessments of future proposed rules. This will be done through a combination of behavioral economics experiments with original data collection, acquisition of existing archival, survey, and commercial databases, and merged data analyses that address the issues discussed above, as well as others that emerge in coming years. To accomplish this, a variety of . activities vvili be done to address three specific aims that together address most of the FDA's research priorities around understanding the role of economics and policies on tobacco use and perceptions.
Aim 1 : assess the impact of FDA regulatory actions and other tobacco control policies on tobacco use and related outcomes, including the impact on trajectories of tobacco use among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products.
Aim 2 : Assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus obtained by tobacco users through a behavioral economics experiment that will quantify the extent of present bias, projection bias, and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus.
Aim 3 : Extend the range of costs and benefits including in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits than that included in previous FDA assessments.

Public Health Relevance

There are numerous challenges inherent in conducting the type of economic impact analysis FDA is required to conduct as part of its rulemaking process. This project will produce new evidence that addresses these challenges and better informs the FDA's economic impact assessments of future proposed rules concerning tobacco products.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgia State University
United States
Zip Code
Shang, Ce; Huang, Jidong; Cheng, Kai-Wen et al. (2016) Global Evidence on the Association between POS Advertising Bans and Youth Smoking Participation. Int J Environ Res Public Health 13:
Nyman, Amy L; Sterling, Kymberle L; Weaver, Scott R et al. (2016) Little Cigars and Cigarillos: Users, Perceptions, and Reasons for Use. Tob Regul Sci 2:239-251
Weaver, Scott R; Majeed, Ban A; Pechacek, Terry F et al. (2016) Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int J Public Health 61:177-88
Lee, Joseph G L; Gregory, Kyle R; Baker, Hannah M et al. (2016) ""May I Buy a Pack of Marlboros, Please?"" A Systematic Review of Evidence to Improve the Validity and Impact of Youth Undercover Buy Inspections. PLoS One 11:e0153152
Nayak, Pratibha; Pechacek, Terry F; Weaver, Scott R et al. (2016) Electronic nicotine delivery system dual use and intention to quit smoking: Will the socioeconomic gap in smoking get greater? Addict Behav 61:112-6
Nayak, Pratibha; Kemp, Catherine B; Redmon, Pamela (2016) A Qualitative Study of Vape Shop Operators' Perceptions of Risks and Benefits of E-Cigarette Use and Attitude Toward Their Potential Regulation by the US Food and Drug Administration, Florida, Georgia, South Carolina, or North Carolina, 2015. Prev Chronic Dis 13:E68
Robinson, R J; Hensel, E C; Roundtree, K A et al. (2016) Week Long Topography Study of Young Adults Using Electronic Cigarettes in Their Natural Environment. PLoS One 11:e0164038
Pechacek, Terry F; Nayak, Pratibha; Gregory, Kyle R et al. (2016) The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive Technology: Results From a National Survey. Nicotine Tob Res 18:1989-97
Lee, Joseph G L; Landrine, Hope; Torres, Essie et al. (2016) Inequities in tobacco retailer sales to minors by neighbourhood racial/ethnic composition, poverty and segregation, USA, 2015. Tob Control 25:e142-e145
Dube, Shanta R; Pathak, Sarita; Nyman, Amy L et al. (2015) Electronic Cigarette and Electronic Hookah: A Pilot Study Comparing Two Vaping Products. Prev Med Rep 2:953-958

Showing the most recent 10 out of 13 publications